This Article Full Text Full Text (PDF) All Versions of this Article: 2007-0198TRv1 38/2/127    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Mutlu, G. M. Articles by Factor, P. PubMed PubMed Citation Articles by Mutlu, G. M. Articles by Factor, P.

Alveolar Epithelial β₂-Adrenergic Receptors

¹ Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and ² Pulmonary, Allergy and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, New York

Correspondence and requests for reprints should be addressed to Gökhan M. Mutlu, M.D., Northwestern University Feinberg School of Medicine, Pulmonary and Critical Care Medicine, 240 E. Huron Street, McGaw M-300, Chicago, IL 60611. Email: g-mutlu{at}northwestern.edu

β₂-adrenergic receptors are present throughout the lung, including the alveolar airspace, where they play an important role for regulation of the active Na⁺ transport needed for clearance of excess fluid out of alveolar airspace. β₂-adrenergic receptor signaling is required for up-regulation of alveolar epithelial active ion transport in the setting of excess alveolar edema. The positive, protective effects of β₂-adrenergic receptor signaling on alveolar active Na⁺ transport in normal and injured lungs provide substantial support for the use of β-adrenergic agonists to accelerate alveolar fluid clearance in patients with cardiogenic and noncardiogenic pulmonary edema. In this review, we summarize the role of β₂-adrenergic receptors in the alveolar epithelium with emphasis on their role in the regulation of alveolar active Na⁺ transport in normal and injured lungs.

Key Words: pulmonary edema • acute respiratory distress syndrome • acute lung injury • alveoli • albuterol

CLINICAL RELEVANCE This review will help clinicians understand the mechanisms by which β2-adrenergic therapy may be useful in the management of acute lung injury.